Torrent Pharma's Major Acquisition Moves in the Pharma Industry

In a strategic expansion, Torrent Pharmaceuticals will acquire a controlling 46.39% stake in JB Chemicals and Pharmaceuticals. The acquisition comes from New York's investment firm KKR, indicating a formidable maneuver in the pharmaceutical landscape.

Torrent and JB Pharmaceuticals plan to merge following the acquisition, a move that reflects Torrent's dedication to expanding its foothold in the pharmaceutical sector.

This transaction places JB Pharma's total equity valuation at an impressive 256.89 billion rupees, underscoring the significant impact of this development in the industry.

(With inputs from agencies.)